Merck-მა შვეიცარიული MoonLake-ის 3 მილიარდ დოლა...
Merck's Third-Quarter Earnings and Sales Top Fo...
Merck & Co., Inc. (NYSE:MRK) Shares Sold by Fif...
Merck beats quarterly sales estimate
Merck | Home
Merck KGaA sees future for enpatoran in lupus s...
Collaborators | My WordPress
Merck just dashed the last remaining hopes for ...
Head Of Data Governance (All Genders) | London ...
Merck Presents Results on Efficacy and Safety o...
Merck Challenges U.S. Government’s New Powers t...
German Merck bests US Merck in UK copyright tus...
By IPP Bureau | December 17, 2024
Merck Group - Wikipedia
Merck tops earnings estimates on strong demand ...
Merck Offering Refunds to 340B Covered Entities...
Merck In Profile: Family-Owned Giant With A Lon...
FDA nixes Merck’s shot at getting Januvia cardi...
Merck to spin off assets with $6.5B in sales; 4...
Merck gets positive EU CHMP opinions for Keytru...
Merck sets up €20m fund for Israeli biotech cos...
Merck to Invest € 70 Million to Expand its Reag...
Is Merck a Buy After Covid-Treatment Report? Ch...
Merck gets FDA Breakthrough Therapy designation...
Merck Announces Acquisition of Alydia Health on...
Merck discontinues some cancer drug development...
Merck Extends 2 Million Euros Support to India ...
Rush to buy Merck’s COVID-19 pill risks leaving...
Merck
Three million recognition moments: How Merck re...
Sehr Merck würdig: Der neue Markenauftritt des ...
Merck beats on revenue boosted by Keytruda sale...
Merck KGaA reports positive results for M7824, ...
Merck KGaA Shares Spike After FDA Approves Skin...
Early Phase 1 Data from Merck’s Oncology Pipeli...